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activity in rat renal proximal tubules
CHARLES L. EDELSTEIN, HONG LING, PATRICIA E. GENGARO, RAPHAEL A. NEMENOFF, BEN A. BAHR,
and ROBERT W. SCHRIER
Department of Medicine, University of Colorado School of Medicine, Denver, Colorado and Center for the Neurobiology of Learning
and Memoiy, University of California, Irvine, California, USA
Effect of glycine on prelethal and postlethal increases in calpain activity
in rat renal proximal tubules. The effect of glycine on hypoxia- and
ionomycin-induced increases in calpain activity in rat proximal tubules was
determined. Calpain activity was determined both in vitro and in the intact
cell using the fluorescent substrate N-succinyl-Leu-Leu-VaI-Tyr-7- amido-
4-methyl coumarin (N-succinyl-Leu-Leu-Val-Tyr-AMC) and Western
blotting for calpain-specific spectrin breakdown products (BDP), respec-
tively. At 7.5 minutes of hypoxia (prelethal injury model) there was a
significant (10-fold) increase in in Vitro calpain activity that was not
inhibited by glycine. At 15 minutes of hypoxia (postlethal injury model)
there was a further increase in calpain activity that was inhibited by
glycine. Normoxic tubules incubated with the calcium ionophore ionomy-
cm (5 tLM) for two minutes and 10 minutes had a significant increase in
calpain activity that was not inhibited by glycine. After 15 minutes of
hypoxia in the presence of glycine, there was an increase in calpain-specific
spectrin breakdown products (BDP) in both Triton X-100 soluble and
cytosolic extracts from proximal tubules. Glycine in concentrations up to
10 mM had no direct effect on the in vitro calpain activity of purified
calpains. The present study demonstrates that: (1) prelethal increases in
calpain activity stimulated by hypoxia and ionomycin treatment are not
affected by glycine; (2) calpain-mediated spectrin breakdown during
hypoxia occurs in the presence of glycine; (3) glycine does prevent the
additional postlethal increase in calpain activity probably by maintaining
membrane integrity to calcium influx.
Glycine is a well-known cytoprotective agent against proximal
tubular injury [1, 2]. However, many of the pathophysiological
events that occur in in vitro models of proximal tubule injury, such
as ATP depletion [3—5], cytoskeletal changes [6, 7], prelethal
influx of Ca2 [5, 8], activation of phospholipase A2 (PLA2) [9]
and nitric oxide synthase (NOS) [10] are not affected by glycine.
These events therefore are more likely to be potential mediators
of in vivo proximal tubule injury where glycine is present at
physiological concentrations [1, 11].
Prelethal increases in free cytosolic calcium ([Ca2J1) during
hypoxia and ionomycin treatment have been shown to activate the
Ca2-dependent protease, calpain, in proximal tubules [12, 13].
These prelethal increases in [Ca2] are not inhibited by glycine
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[5, 8]. However, as membrane integrity becomes impaired in the
absence of glycine in the media, there is a massive influx of Ca2
from the extracellular medium [14, 15]. Glycine prevents this
secondary Ca2' influx by maintaining structural membrane integ-
rity of the cell by a mechanism that is as yet incompletely
understood.
It has been suggested that glycine may exert its cytoprotective
effect by inhibition of protease activity [16]. In pre-lethal anoxic
hepatocyte injury, glycine cytoprotection was demonstrated to be
in part due to inhibition of Ca2-dependent degradative, nonly-
sosomal enzymes, including calpains [17]. There have also been
preliminary reports that glycine cytoprotection against hypoxic
and antimycin A-induced injury in rat proximal tubules may be
mediated by calpain inhibition [18, 19]. However, whether this
effect of glycine to inhibit calpain activity is a direct effect or the
result of cytoprotection is controversial. In hepatocytes glycine
has a direct effect on m-calpain more than r-calpain [17].
However, in proximal tubules glycine did not have a direct effect
on calpain activity [18]. Specifically, if glycine inhibits calpain
directly, then the early prelethal increase in calpain activity would
be blocked by glycine regardless of the glycine-independent
increase in [Ca2]1. On the other hand, if glycine does not directly
inhibit calpain activity, it would be expected that the prelethal
increase in Ca2-mediated calpain activity would persist. In either
case, further increases in calpain activity during postlethal Ca2
influx should be prevented by glycine.
The present study was designed to (1) dissociate prelethal
versus postlethal effects of hypoxia or ionomycin treatment on
calpain activity, and (2) determine whether the cytoprotective
effect of glycine is mediated by calpain inhibition.
METHODS
Reagents
Glycine, digitonin, hyaluronidase type III from sheep testes,
N-succinyl-Leu-Tyr-7-amido-4-methyl coumarin (N-succinyl-Leu-
Tyr-AMC) and dimethyl sulfoxide (DMSO) were purchased from
Sigma Chemical Co. (St. Louis, MO, USA). N-succinyl-Leu-Leu-
Val-Tyr-AMC and AMC were made by the Peptide Institute
(Osaka, Japan), and was obtained from Peptides International
(Louisville, KY, USA). lonomycin and purified j.t-calpain (from
porcine erythrocytes) was purchased from Calbiochem (San Di-
ego, CA, USA); collagenase type B (lot number OFAA133) from
Boehringer Mannheim (Indianapolis, IN, USA); fura 2 penta-
potassium from Molecular Probes (Eugene, OR, USA); fatty
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acid-free bovine albumin from ICN (Cleveland, OH, USA);
polivinylidene diflouride (PVDF) membrane for immunoblotting
from Millipore Corp. (Bedford, MA, USA). Rabbit polyclonal
antibodies developed against the amino-terminal of the calpain
cleavage site in alpha spectrin [breakdown product specific anti-
bodies (BDPn)j were obtained from Dr. Ben Bahr, University of
California (Irvine, CA, USA) [201. Horseradish peroxidase con-
jugated sheep anti-mouse and donkey anti-rabbit immunoglobulin
G from Amersham Corp. (Arlington Heights, IL, USA); chemi-
luminescence (ECL) kit from Amersham Corp.; and prestained
protein markers were from BIORAD (Temecula, CA, USA).
Preparation of tubules
Proximal tubules were isolated from kidney cortex of male
Sprague-Dawley rats (200 to 300 g body wt) using collagenase
digestion and percoll centrifugation [21, 221. Six milliliter aliquots
of tubule suspension (—1 to 2 mg/mI) were placed in siliconized 25
ml Erlenmeyer flasks for a "recovery" period consisting of the
following: (1) gassing with 95% 02-5% CO2 for five minutes on
ice; (2) flasks were then capped with rubber stoppers and kept at
room temperature for five minutes; and (3) flasks were then
placed in a shaking water bath at 37°C for 10 minutes. To create
hypoxia, the tubule suspension was regassed for five minutes with
95% N2-5% CO2 at a rate of 3 liter/mm [23]. After regassing, the
flasks were closed and kept in the shaking water bath for the
period of hypoxia studied. At the end of the hypoxic period, 1 ml
of tubule suspension was sampled for measurement of LDH and
2 ml for calpain activity.
The calcium ionophore, ionomycin, was used to induce an
increase in [Ca2],. A stock solution of 1 mrvi ionomycin in DMSO
was used. The increase in [Ca2] in freshly isolated rat proximal
tubules occurs after 30 seconds of exposure to ionomycin [81.
Normoxic tubules were exposed to ionomycin (5 !IM)for 2 and 10
minutes. Control tubules were exposed to the vehicle, DMSO.
Glycine studies
A 200 m stock solution of glycine in distilled deionized water
was prepared fresh each day. After the recovery period, glycine 2
m was added to the tubules before the induction of hypoxia and
ionomycin treatment.
Measurement of lactate dehydrogenase release and protein
Lactate dehydrogenase (LDH) release was measured to evalu-
ate cell damage, as previously described [24, 25]. The percentage
of LDH released from tubules was calculated by determining the
ratio of LDH in the supernatant compared to that in the lysed
tubule pellet plus the supernatant. Tubule protein was measured
by the Lowry method using bovine serum albumin as standard
[261.
In vitro calpain assay
The calpain assay used in this study is based on that described
by Sasaki et al for purified porcine kidney calpain [27]. N-succinyl-
Leu-Leu-Val-Tyr-AMC was used as a susceptible substrate for
calpain [27]. A stock solution of 10 m was prepared in DMSO
and stored at —20°C between use. The preparation of cytosolic
extracts from proximal tubules and the calpain assay in freshly
isolated proximal tubules has recently been described in detail by
us [12, 13].
Briefly, the calpain assay was performed as follows. After
exposure to normoxia, to ionomycin or to hypoxia, the tubule
pellet was separated from 2 ml tubule suspension by centrifuga-
tion. The imidazole-HC1 buffer used contained imidazole 63.2
mM—mercaptoethanol 10 mivi, pH 7.3. The tubule pellet was
immediately resuspended in a calcium free imidazole—HCI buffer
containing in addition 1 mrvi EDTA and 10 mrvi EGTA (pH 7.3).
The suspension was then incubated with digitonin (10 tM) at 37°C
in a shaking water bath for five minutes. Ten micrometers of
digitonin selectively permeabilized the plasma membrane but did
not destroy lysosomal or mitochondrial membranes of hepato-
cytes [28] or mitochondrial membranes of rat proximal tubules
[211. In separate experiments, using the lysosomal dye Lucifer
Yellow and a video imaging microscope that has been previously
described [29], our laboratory confirmed that 10 iM digitonin
selectively permeabilizes the plasma membrane of isolated rat
proximal tubules without affecting the lysosomal membrane.
Thus, 10 M digitonin released cytosolic enzymes including cal-
pain, while keeping the lysosomal membrane intact. After incu-
bation with digitonin, the tubule pellet and supernatant contain-
ing released calpain were again separated by centrifugation.
Calpain activity in the tubule pellet after digitonin incubation was
zero, confirming that all the calpain had been released into the
supernatant. The calpain assay was then performed on this
supernatant as follows: 0.5 ml supernatant (0.5 to 1 mg tubule
protein) and 10 d of the substrate N-succinyl-leu-leu-val-tyr-
AMC were added to the imidazole buffer with or without 5 mM
CaCI2. The total volume of the assay solution was made up to 2 ml
with the imidazole buffer. The solution was incubated for 30
minutes at 37°C in a shaking water bath. In the assay performed
without CaC12, the imidazole—HCI buffer containing 1 mi
EDTA and 10 mvi EGTA was used. After the a 30 minute
incubation, fluorescence at 380 nm excitation and 460 nm emis-
sion was determined using a Hitachi F2000 spectrophotometer.
Calpain activity was determined as the difference between the
calcium dependent fluorescence and the non-calcium dependent
fluorescence. An AMC standard curve was determined for each
experiment. Calpain activity was expressed in pmol AMC released
per minute of incubation time per mg of tubule protein.
Calpain activity measured in the media used for incubation of
the tubules was negligible in normoxia, hypoxia and ionomycin
treatment, confirming that calpain does not leak out of the tubules
into the media [12].
The calpain substrate used in our assay, N-succinyl-Leu-Leu-
Val-Tyr-AMC, has been shown to be proteolyzed in vitro by the
cathepsin, papain [27]. Therefore, to ensure the calpain selectivity
of our assay and exclude any possible effect of lysosomal leakage
of cathepsins in our calpain assay, the following measures were
taken: (1) digitonin, which releases cytoplasmic contents while
keeping lysosomes intact, thus limiting release of lysosomal
cathepsins, was used to lyse the cells [8]; (2) the assay was
performed at a pH of 7.3 at which cathepsins are known to be
inactivated [301; and (3) calpain activity was defined and calcu-
lated as calcium-dependent activity, thus excluding cathepsin
activity, which is strictly calcium-independent [30].
Rat lung extract
Partially purified m-calpain controls were obtained from nor-
mal nonperfused rat lung tissue by a technique modified from
Waxman and Krebs [31].
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Calpain assay in intact cells by detection of spectrin breakdown
products
Proteolysis of spectrin to its calpain specific breakdown prod-
ucts is an established measurement of calpain activation in intact
cells [20, 32, 33]. Both Triton X-100 soluble and cytosolic fractions
from proximal tubules were immunoblotted with antibodies de-
veloped against the amino-terminal of the calpain cleavage site in
alpha spectrin (BDPn).
Preparation of triton soluble fractions
The association of spectrin with the cytoskeleton was deter-
mined by its solubility in Triton X-100. The cytoskeletal proteins
that dissociate from the cytoskeleton become Triton X-100 solu-
ble [7]. Freshly isolated rat proximal tubules were exposed to
normoxic or hypoxic conditions for 15 minutes in the presence and
absence of glycine. One milliliter of tubule suspension was mixed
with an equal volume of ice-cold lysis buffer [0.5% Triton X-100,
300 m sucrose, 5 mM tris(hydroxymethyl]aminomethane (Tris)-
HCI, pH 7.4] containing the protease inhibitors pepstatin 20 tM,
leupeptin 20 rM, aprotonin 1000 U/ml and phenylmethyl-sulfonyl
fluoride (PMSF) 1 m for 10 minutes on ice. The extracted
suspension was then centrifuged at 5000 g for 10 minutes. The
Triton soluble proteins were precipitated from the supernatant
with 3.5 ml of 100% methanol and pelleted at 4,000 g for 10
minutes. The Triton soluble proteins were resuspended in poly-
acrylamide gel electrophoresis (PAGE) buffer [5% sodium dode-
cyl sulfate (SDS), 25% sucrose, 5 m Tris-HCI and 5 mrvi EDTA]
and mixed with 5x sample buffer (containing 0.35 M Tris base,
10% glycerol, 0.01% bromophenol blue, 15% SDS, 3.6 m'vi
beta-mercaptoethanol, pH 6.5) and stored at —20°C. Samples
were boiled at 100°C for three minutes before loading onto the
gel. For spectrin, 100 g samples were loaded onto the gel. The
total protein in aliqouts precipitated from the Triton soluble
fraction was resuspended in SDS-PAGE buffer and measured by
the Lowiy method using bovine serum albumin as the standard
[26].
Preparation of cytosolic (soluble) fractions
Subcellular fractionation was performed as described by
Michel, Li and Busconi [34]. Normoxic and hypoxic tubules
(approximately 6 to 8 mg protein) in the presence of glycine (2
mM) were pelleted by gentle centrifugation. Pellets were resus-
pended in 2 ml homogenizing buffer (50 mrvi Tris-HC1, 1 mM
EDTA, 2 ms b-mercaptoethanol, 1 mrvi EDTA, pH 7.4) with the
protease inhibitors pepstatin 20 JiM, leupeptin 20 JiM, phenyim-
ethyl-sulfonyl fluoride (PMSF) 200 JiM. Tubules were then dis-
rupted by freeze-thawing three times followed by homogenization
in a teflon-glass homogenizer. Homogenate was then centrifuged
at 3000 g for five minutes. The supernatant was centrifuged at
100,000 g at 4°C for one hour. The high-speed supernatant was
kept as the cytosolic fraction. Aliquots of the cytosolic fraction
were mixed with 5 X sample buffer and frozen at — 20°C. Aliquots
were kept for protein determination using the Bradford method
as described in the Bio-rad protein assay kit with bovine serum
albumin as standards. Samples were boiled at 100°C for three
minutes before loading onto the gel. For spectrin, 100 jig samples
were loaded onto the gel.
Western blots
Western blotting was performed using a standard protocol [35,
36]. Extracted proteins were separated by electrophoresis on a
denaturing 7.5% SDS polyacrilamide gel (constant current of 150
mA for 2 hr). Proteins were then transferred to a polivinylidene
diflouride (PVDF) membrane by wet electroblotting (100 V for
105 mm). Blots were blocked for one hour with 5% non fat dry
milk in ]ITBS (20 mri Tris base, 137 mM NaCI, 0.1% Tween 20,
pH 7.5). Western blot analysis was performed with rabbit poly-
clonal antibodies developed to the amino-terminal of the calpain
cleavage site in alpha spectrin [breakdown product specific anti-
body (BDPn)] [20]. The blotted proteins were then probed with
BDPn antibodies (1:50) overnight at 4°C. Secondary antibody
used was horseradish peroxidase conjugated donkey anti-rabbit
immunoglobulin G 1:1000. BDPn protein (147 kDa) were de-
tected by enhanced chemiluminescence (ECL) according to man-
ufacturer's instructions. Prestained proteins markers were used
for molecular mass determinations. Positive controls for BDPs
were run with calcium-treated hippocampal slices [20].
Statistical analysis
Multiple group comparisons were done using the analysis of
variance (ANOVA) with post-test according to Newman-Keuls. A
P value of less than 0.05 was considered statistically significant.
Values are expressed as means standard error (sEM).
RESULTS
Effect of glycine on hypoxia-induced calpain activity
At 7.5 minutes there was no increase of LDH release in hypoxic
and glycine treated tubules compared to controls (Fig. 1). There
was a prelethal increase in calpain activity that was not signifi-
cantly decreased by glycine. Calpain activity was 17 7 pmol/
mm/mg protein in controls, 166 22 pmol/min/mg protein after
7.5 minutes hypoxia (P < 0.001 vs. control) and 147 22
pmol/min/mg protein in hypoxic tubules treated with glycine (P <
0.001 vs. control, NS vs. hypoxia alone; N = 12; Fig. 1).
At 15 minutes of hypoxia there was a fourfold increase of LDH
release in hypoxic tubules that was completely prevented by
glycine (Fig. 2). Calpain activity increased to a higher level than
seen at 7.5 minutes of hypoxia and glycine significantly reduced
the calpain activity to a level seen at 7.5 minutes of hypoxia.
Calpain activity was 7 7 pmol/min/mg protein in controls, 308
42 pmol/min/mg protein after 15 minutes of hypoxia (P < 0.00 1 vs.
control, P < 0.05 vs. 7.5 mm hypoxia), and 138 23 pmol/min/mg
protein in hypoxic tubules treated with glycine (P < 0.01 vs.
control, P < 0.01 vs. hypoxia alone; N = 5; Fig. 2).
Effect of glycine on ionomycin-induced calpain activity
Normoxic tubules were incubated with 5 JiM ionomycin for 2
and 10 minutes, in the presence and absence of glycine. Control
tubules were incubated with DMSO, the vehicle for the ionomy-
cm.
At two minutes there was no increase of LDH release in
ionomycin and glycine treated tubules compared to controls (Fig.
3). There was a prelethal increase in calpain activity that was not
decreased by glycine. Calpain activity was 80 40 pmol/min/mg
protein in normoxic controls, 358 64 pmol/min/mg protein after
two minutes of ionomycin (P < 0.01 vs. control) and 297 73
pmol/min/mg protein in ionomycin treated tubules preincubated
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release at 7.5 minutes of hypoxia (H) (prelethal injury model). There was
a prelethal increase in calpain activity compared to normoxic controls (N).
Addition of 2 mcvi glycine did not inhibit the prelethal increase in calpain
activity (N = 12).
with glycine (P < 0.05 vs. control, NS vs. ionomycin treatment
alone; N = 4; Fig. 3).
At 10 minutes there was an increase of LDH release in
ionomycin treated tubules that was prevented by glycine (Fig. 4).
There was an increase in calpain activity compared to normoxic
controls that was not decreased by glycine. Calpain activity at 10
minutes was similar to that at two minutes. Calpain activity was
80 40 pmol/min/mg protein in controls, 301 33 pmol/min/mg
protein after 10 minutes ionomycin (P < 0.01 vs. control) and
272 5 pmol/min/mg protein in ionomycin treated tubules
preincubated with glycine (P < 0.05 vs. control, NS vs. ionomycin
treatment alone; N = 4; Fig. 4).
Calpain-specific spectrin breakdown products (intact cell assay)
Triton X-100 soluble and cytosolic extracts from normoxic and
hypoxic (15 mm) tubules were immunoblotted for spectrin break-
down products (BDPn). In Triton X-100 soluble extracts there
was an increase in BDPn even in the presence of glycine (Fig. 5).
In cytosolic extracts there was also an increase in BDPn in the
presence of glycine (Fig. 6).
Direct effect of glycine on calpain activity
To ascertain whether glycine directly inhibits calpain activity,
using the substrate N-succinyl-Leu-Tyr-AMC that we have found
<
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Fig. 2. Effect of 2 mcvi glycine (Gly) on (A) calpain activity and (B) LDH
release at 15 minutes hypoxia (H) (postlethal injury model). At 15
minutes of hypoxia there was a fourfold increase of LDH release in
hypoxic tubules that was completely prevented by glycine. Calpain activity
increased to a higher level than seen at 7.5 minutes of hypoxia, and glycine
significantly reduced the calpain activity to a level seen at 7.5 minutes of
hypoxia (N = 5).
to be more sensitive than N-succinyl-Leu-Leu-Val-Tyr-AMC for
detecting activity of purified calpains, we measured the in vitro
activity of purified calpains in the absence and presence of
increasing doses of glycine. The calpain activity of purified
calpains was not affected by 2 m and 10 mM glycine. The calpain
activity (pmol!min!mg) of purified -calpain (20 g) was 495 33
with no added glycine, 561 20 after the addition of 2 ma glycine
and 522 40 after the addition of 10 mivi glycine (N = 3). The
calpain activity (pmol/min/mg) of partially purified m-calpain (280
j.tg of lung extract) was 18 1 with no added glycine, 18 1 after
addition of 2 mivi glycine and 17 2 after the addition of 10 mM
glycine (N = 3). The calpain activity (pmol/min/mg) of extracts(500 g of tubule protein) from hypoxic tubules was 39 8 with
no added glycine, 36 8 after addition of 2 mrvi glycine and 38
8 after addition of 10 mrvi glycine (N = 5). The calpain activity
(pmol/min/mg) of extracts (500 itg of tubule protein) from
ionomycin (5 ELM) treated tubules was 26 8 with no added
glycine, 30 10 after addition of 2 mM glycine and 30 10 after
addition of 10 mcvi glycine (N = 5).
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Fig. 3. Effect of two minutes of incubation of 5 LM ionomycin (I) and 2
mM glycine (Gly) on (A) calpain activity and (B) LDH release in normoxic
(N) tubules. There was a prelethal increase in calpain activity in ionomycin
treated tubules compared to normoxic controls. Addition of 2 mtvi glycine
did not inhibit the prelethal increase in calpain activity (N = 4).
DISCUSSION
Calpain is the major Ca2-dependent cytosolic protease and is
ubiquitously present in most cell types [37, 38]. Calpain exists in
the cytosol as the inactive proenzyme, procalpain. Procalpain
translocates from the cytosol to membrane in the presence of
Ca2. Autocatalytic activation of procalpain occurs when it at-
taches to a phosphatidylinositol -binding site on the cell membrane
(membrane activation theory of calpain activation) [38, 39].
Binding to the membrane-phospholipid is proposed to lower the
Ca2 concentration required for autolysis. The activated calpain is
either released into the cytosol, where with its reduced Ca2
requirement it is able to proteolyze substrate proteins, or it
remains associated with the membrane and degrades cytoskeletal
proteins involved in the interaction of the cell cytoskeleton with
the plasma membrane. This activated calpain is measured in the in
vitro assay. Since calpain is strictly a Ca2-dependent enzyme, the
calpain activity measured in vitro is defined as only that which is
Ca2'-dependent. There is not much further autocatalytic conver-
sion of procalpain to calpain in the in vitro assay as there is no cell
membrane present.
Calpain is now known to be a mediator of hypoxic/ischemic
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Fig. 4. Effect of 10 minutes of incubation of 5 ILM ionomycin (I) and 2 mM
glycine (Gly) on (A) calpain activity and (B) LDH release in normoxic (N)
tubules. There was an increase in LDH release compared to normoxic
controls. Addition of 2 m'vi glycine gave complete cytoprotection against
cell membrane damage. There was an increase in calpain activity similar to
that seen at two minutes ionomycin incubation. Addition of 2 mM glycine
had no effect on ionomycin-induced calpain activity at 10 minutes (N 4).
injury to brain, liver, heart and kidneys [12, 13, 40—43]. In
proximal tubules exposed acutely to cyclosporine, calpain activity
increased, suggesting that calpain is involved in acute cyclosporin
toxicity [44]. Also in proximal tubules, HgCI2 toxicity correlated
with increased ionized Ca2 and the toxicity was diminished by
calpain inhibitors [45]. Thus, the role of calpain as a mediator of
cell injury is well established.
It is also well known that the availability of glycine in a cell is a
major determinant of lethal cell membrane damage to anoxic,
hypoxic, ischemic and toxin-induced insults in hepatocytes, prox-
imal tubules and endothelial cells [1, 2, 17, 46, 47]. Since the
physiological concentrations of glycine present in vivo [1, 11] are
cytoprotective, the mechanism of calpain-induced structural and
functional changes during cell injury is better understood and
needs to be assessed in the presence of glycine. Studies were
therefore undertaken to determine whether the cytoprotective
effects of glycine involve calpain inhibition.
We have previously demonstrated the calcium-dependency of
hypoxia-induced calpain activity [13]. Low [Ca2] induced by
both a low Ca2 medium and the intracellular Ca2 chelator 1,22-
Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA),
attenuated the increase in calpain activity seen at 15 minutes of
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Fig. 5. Calpain specific spectrin breakdown products (BDP) in Triton
X-100 soluble extracts from normoxic (N) and hypoxic (H; 15 mm)
tubules. BDP were increased in the presence and absence of 2 m glycine
(Gly). Pos represents positive controls (calcium-treated hippocampal
slices; N = 3).
hypoxia. This attenuation of calpain activity by low [Ca2]1 was
also observed at 7.5 minutes before hypoxia-induced cell mem-
brane damage (prelethal injury model). As further evidence of the
calcium-dependency of calpain activity, we have demonstrated in
normoxic proximal tubules that the calcium ionophore, ionomy-
cm, which is known to induce a dose-dependent increase in
[Ca2]1, also induces a dose-dependent increase in calpain activity
that preceeds cell membrane damage [121. Using Fura-2/AM and
Video imaging fluorescence microscopy (VIFM) [8], we have
confirmed in PT that 3 M and 5 j.LM ionomycin induce a
dose-dependent increase in [Ca2] within 30 seconds to levels of
1140 nM and 2160 nM, respectively.
We have previously shown in rat proximal tubules that the
[Ca2]1 increases from 100 n to 400 n during 7.5 minutes of
hypoxia, and that this rise in [Ca2]1 preceeds cell membrane
injury as measured by propidium iodide (P1) uptake by the nuclei
of necrotic cells [8]. Glycine was also shown to have no effect on
this early prelethal increase in [Ca2]1 [8]. In the present study,
calpain activity was therefore measured at 7.5 minutes of hypoxia.
There was a large increase in calpain activity at 7.5 minutes of
hypoxia that was not significantly inhibited by glycine (Fig. 1).
However, the postlethal increase in [Ca2]1 during hypoxic
injury is inhibited by glycine [5, 8]. At 15 minutes, hypoxia-induced
LDH release was 40%. In these lethally damaged cells, the cell
membranes become Ca2-permeable, [Ca2] increases and even-
tually equilibrates with that of the extracellular medium [15]. As a
consequence of this postlethal increase in [Ca2]1, there was a
further increase in calpain activity at 15 minutes of hypoxia as
compared to 7.5 minutes of hypoxia. Glycine, by preventing the
postlethal increase in [Ca2]1, also prevented the further increase
in calpain activity. Specifically, calpain activity in the presence of
glycine was the same at 7.5 and 15 minutes of hypoxia (Figs. 1 and
2).
By inducing an increase in [Ca2]1, ionomycin (5 iM) stimu-
lated an increase in calpain activity to levels seen at 15 minutes of
hypoxia and higher than those seen at 7.5 minutes of hypoxia. This
increase in calpain activity was maximal after tvo minutes of 5 M
ionomycin, before the LDH release occurred. The increase in
calpain activity induced by ionomycin was not inhibited by glycine.
This finding is compatible with earlier results that ionomycin-
induced increases in [Ca2] are not affected by glycine [5]. Thus,
the cytoprotective effect of glycine seen at 10 minutes of ionomy-
cm treatment is not mediated by inhibition of calpain.
Proteolysis of spectrin to its calpain-specific breakdown prod-
ucts is established as a measurement of calpain activation in intact
cells [20, 32, 33]. This technique was therefore used to comple-
ment the direct in vitro measurement of calpain activity. A
prelethal increase in calpain-specific spectrin breakdown products
in rat proximal tubules was observed in the presence of glycine,
thus confirming the prelethal calpain activation that was detected
in the in vitro assay. A spectrin breakdown pattern similar to that
induced by j.-calpain proteolysis of spectrin has been demon-
strated in whole kidney extracts after both early [48] and late [14]
ischemia. Molitoris, DahI and Hosford [49] have recently demon-
strated that intact spectrin in cultured proximal tubule cells
dissociates from the cytoskeleton and translocates to the cyto-
plasm in a prelethal model of antimycin A-induced ATP deple-
tion. In this previous study, spectrin was not degraded during
prolonged ATP depletion. However, it was acknowledged in the
paper that it was possible that the antibody used did not recognize
spectrin breakdown products.
In hepatocytes, glycine has been found to more potently inhibit
the high calcium-sensitive isoform, m-calpain, than the low calci-
um-sensitive isoform, i-calpain [17]. The activity of m-calpain in
hepatocytes is fivefold greater than the activity of it-calpain [50].
It is also known that the increase in [Ca2]1 during anoxia in rat
hepatocyte suspensions is biphasic, consisting of an early small
increase in [Ca2]1 from 127 n to 389 n and a later larger
increase reaching 1450 nM [51]. Thus, in hepatocytes, glycine's
inhibition of later larger increases in [Ca2]1 may inhibit activation
of the high calcium-sensitive m-calpain. In rat proximal tubules,
the low calcium-sensitive isoform, -calpain, is the active calpairi
isoform during hypoxia and ionomycin treatment [13].
In summary, calpain activity was measured both in vitro and in
the intact cell. The present results demonstrate that (1) prelethal
increases in calpain activity induced by hypoxia and the calcium
ionophore, ionomycin, are not inhibited by glycine; and (2) the
additional calpain activation observed after postlethal accelera-
tion of calcium entry into the cell was inhibited by glycine. This
study is also the first demonstration of prelethal hypoxia-induced
spectrin breakdown in freshly isolated proximal tubules.
Thus, the cytoprotective effects of glycine in proximal tubules
are not directly mediated by calpain inhibition. Rather, glycine
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Fig. 6. Calpain-specific spectrin breakdown products (BDP) in cytosolic
extracts from normoxic (N) and hypoxic (H; 15 mm) tubules. BDP were
N N H H increased even in the presence of glycine (Gly). Pos represents positivecontrols (calcium treated hippocampal slices; N = 3).
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prevents hypoxia-induced membrane damage and thus further
postlethal increases in [Ca2j1 and calpain activity. The study of
prelethal changes in Ca2-dependent enzymes therefore needs to
be performed in the presence of glycine.
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